Articles from Hyku Biosciences

BURLINGTON, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Hyku Biosciences, a pioneer in precision medicine, today announced the appointment of Keith Wilcoxen, PhD, as Chief Scientific Officer. Dr. Wilcoxen has more than 25 years of experience advancing new therapies through preclinical and early clinical development.

John Gustofson, MS, MBA appointed to the Board of Directors

Kleem Chaudhary, Ph.D. appointed as President and Chief Executive Officer